368 related articles for article (PubMed ID: 9191052)
21. Pbx modulation of Hox homeodomain amino-terminal arms establishes different DNA-binding specificities across the Hox locus.
Chang CP; Brocchieri L; Shen WF; Largman C; Cleary ML
Mol Cell Biol; 1996 Apr; 16(4):1734-45. PubMed ID: 8657149
[TBL] [Abstract][Full Text] [Related]
22. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains.
LeBrun DP; Matthews BP; Feldman BJ; Cleary ML
Oncogene; 1997 Oct; 15(17):2059-67. PubMed ID: 9366523
[TBL] [Abstract][Full Text] [Related]
23. New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia.
Numata S; Kato K; Horibe K
Leukemia; 1993 Sep; 7(9):1441-4. PubMed ID: 8103813
[TBL] [Abstract][Full Text] [Related]
24. High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.
Bijl J; Sauvageau M; Thompson A; Sauvageau G
Genes Dev; 2005 Jan; 19(2):224-33. PubMed ID: 15655112
[TBL] [Abstract][Full Text] [Related]
25. NMR studies of the pbx1 TALE homeodomain protein free in solution and bound to DNA: proposal for a mechanism of HoxB1-Pbx1-DNA complex assembly.
Jabet C; Gitti R; Summers MF; Wolberger C
J Mol Biol; 1999 Aug; 291(3):521-30. PubMed ID: 10448033
[TBL] [Abstract][Full Text] [Related]
26. Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2.
Smith KS; Jacobs Y; Chang CP; Cleary ML
Oncogene; 1997 Jun; 14(24):2917-26. PubMed ID: 9205098
[TBL] [Abstract][Full Text] [Related]
27. Pbx1 is required for Hox D3-mediated angiogenesis.
Charboneau A; East L; Mulholland N; Rohde M; Boudreau N
Angiogenesis; 2005; 8(4):289-96. PubMed ID: 16328158
[TBL] [Abstract][Full Text] [Related]
28. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials.
Kamps MP; Look AT; Baltimore D
Genes Dev; 1991 Mar; 5(3):358-68. PubMed ID: 1672117
[TBL] [Abstract][Full Text] [Related]
29. Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia.
Bijl J; Krosl J; Lebert-Ghali CE; Vacher J; Mayotte N; Sauvageau G
Oncogene; 2008 Oct; 27(49):6356-64. PubMed ID: 18679416
[TBL] [Abstract][Full Text] [Related]
30. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
[TBL] [Abstract][Full Text] [Related]
31. Concerted dynamics link allosteric sites in the PBX homeodomain.
Farber PJ; Mittermaier A
J Mol Biol; 2011 Jan; 405(3):819-30. PubMed ID: 21087615
[TBL] [Abstract][Full Text] [Related]
32. The HoxB1 hexapeptide is a prefolded domain: implications for the Pbx1/Hox interaction.
Slupsky CM; Sykes DB; Gay GL; Sykes BD
Protein Sci; 2001 Jun; 10(6):1244-53. PubMed ID: 11369863
[TBL] [Abstract][Full Text] [Related]
33. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
Casagrande G; te Kronnie G; Basso G
Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
[TBL] [Abstract][Full Text] [Related]
34. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
[TBL] [Abstract][Full Text] [Related]
35. Structural determinants within Pbx1 that mediate cooperative DNA binding with pentapeptide-containing Hox proteins: proposal for a model of a Pbx1-Hox-DNA complex.
Lu Q; Kamps MP
Mol Cell Biol; 1996 Apr; 16(4):1632-40. PubMed ID: 8657138
[TBL] [Abstract][Full Text] [Related]
36. HOX cofactors expression and regulation in the human ovary.
Ota T; Asahina H; Park SH; Huang Q; Minegishi T; Auersperg N; Leung PC
Reprod Biol Endocrinol; 2008 Oct; 6():49. PubMed ID: 18973687
[TBL] [Abstract][Full Text] [Related]
37. Specific immunologic recognition of the tumor-specific E2A-PBX1 fusion-point antigen in t(1;19)-positive pre-B cells.
Berendes P; Hoogeveen A; van Dijk M; van Denderen J; van Ewijk W
Leukemia; 1995 Aug; 9(8):1321-7. PubMed ID: 7643619
[TBL] [Abstract][Full Text] [Related]
38. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
Baudis M; Prima V; Tung YH; Hunger SP
Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cancer cell proliferation by designed peptide amphiphiles.
Aulisa L; Forraz N; McGuckin C; Hartgerink JD
Acta Biomater; 2009 Mar; 5(3):842-53. PubMed ID: 19249722
[TBL] [Abstract][Full Text] [Related]
40. Pbx-Hox heterodimers recruit coactivator-corepressor complexes in an isoform-specific manner.
Asahara H; Dutta S; Kao HY; Evans RM; Montminy M
Mol Cell Biol; 1999 Dec; 19(12):8219-25. PubMed ID: 10567547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
